European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

Pier Luigi Zinzani; Lionel Karlin; John Radford; Dolores Caballero; Paul Fields; Martine E D Chamuleau; Francesco d'Amore; Corinne Haioun; Catherine Thieblemont; Eva González-Barca; Carlos Grande García; Peter W Johnson; Gustaaf W van Imhoff; Thomas Ng; Karen Dwyer; Franck Morschhauser

doi:10.3324/haematol.2016.146977

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

Pier Luigi Zinzani
, Lionel Karlin
, John Radford
, Dolores Caballero
, Paul Fields
, Martine E D Chamuleau
, Francesco d'Amore
, Corinne Haioun
, Catherine Thieblemont
, Eva González-Barca
, Carlos Grande García
, Peter W Johnson
, Gustaaf W van Imhoff
, Thomas Ng
, Karen Dwyer
, Franck Morschhauser

Affiliatie VU

University of Bologna, Italy [email protected].
Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
University of Manchester and The Christie NHS Foundation Trust, UK.
Hospital Universitario de Salamanca, Spain.
Guy's Hospital, London, UK.
Aarhus University Hospital, Denmark.
Hôpital Henri Mondor, Créteil, France.
Service d'Hématologie Adulte et INSERM UMR1160, Hôpital Saint-Louis, Paris, France.
Institut Català d’Oncologia, Barcelona, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain.
NIHR/CRUK Experimental Cancer Medicine Centre, University of Southampton, UK.
Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Kyowa Kirin Pharmaceutical Development, Inc., Galashiels, Scotland.
Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA.
Unité GRITA, Université de Lille 2, France.

Research output: Contribution to journal › Article › Academic › peer-review

9 Downloads (Pure)

Original language	English
Pages (from-to)	e407-e410
Journal	Haematologica
Volume	101
Issue number	10
DOIs	https://doi.org/10.3324/haematol.2016.146977
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.3324/haematol.2016.146977

European-phase-ii-study-of-mogamulizumab-an-anti-ccr4-monoclonal-antibody-in-relapsedrefractory-peripheral-t-cell-lym.pdfFinal published version, 558 KBLicence: Taverne

Cite this

Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D., d'Amore, F., Haioun, C., Thieblemont, C., González-Barca, E., García, C. G., Johnson, P. W., van Imhoff, G. W., Ng, T., Dwyer, K., & Morschhauser, F. (2016). European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. Haematologica, 101(10), e407-e410. https://doi.org/10.3324/haematol.2016.146977

@article{ef68dd43f6664c50b1028e952290cb7c,

title = "European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma",

author = "Zinzani, \{Pier Luigi\} and Lionel Karlin and John Radford and Dolores Caballero and Paul Fields and Chamuleau, \{Martine E D\} and Francesco d'Amore and Corinne Haioun and Catherine Thieblemont and Eva Gonz{\'a}lez-Barca and Garc{\'i}a, \{Carlos Grande\} and Johnson, \{Peter W\} and \{van Imhoff\}, \{Gustaaf W\} and Thomas Ng and Karen Dwyer and Franck Morschhauser",

year = "2016",

doi = "10.3324/haematol.2016.146977",

language = "English",

volume = "101",

pages = "e407--e410",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "10",

}

Zinzani, PL, Karlin, L, Radford, J, Caballero, D, Fields, P, Chamuleau, MED, d'Amore, F, Haioun, C, Thieblemont, C, González-Barca, E, García, CG, Johnson, PW, van Imhoff, GW, Ng, T, Dwyer, K & Morschhauser, F 2016, 'European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma', Haematologica, vol. 101, no. 10, pp. e407-e410. https://doi.org/10.3324/haematol.2016.146977

TY - JOUR

T1 - European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

AU - Zinzani, Pier Luigi

AU - Karlin, Lionel

AU - Radford, John

AU - Caballero, Dolores

AU - Fields, Paul

AU - Chamuleau, Martine E D

AU - d'Amore, Francesco

AU - Haioun, Corinne

AU - Thieblemont, Catherine

AU - González-Barca, Eva

AU - García, Carlos Grande

AU - Johnson, Peter W

AU - van Imhoff, Gustaaf W

AU - Ng, Thomas

AU - Dwyer, Karen

AU - Morschhauser, Franck

PY - 2016

Y1 - 2016

U2 - 10.3324/haematol.2016.146977

DO - 10.3324/haematol.2016.146977

M3 - Article

SN - 0390-6078

VL - 101

SP - e407-e410

JO - Haematologica

JF - Haematologica

IS - 10

ER -